Mattias Furumalm

Mattias Furumalm is a seasoned medical professional with extensive experience in the pharmaceutical industry, currently serving as Global Medical Program Manager at Camurus since March 2022. Prior to this role, Mattias held various positions at Sanofi Genzyme from November 2015 to March 2022, including Nordic & Baltic Medical Lead for Rare Diseases and Medical Advisor. Earlier experience at Eli Lilly and Company spanned from July 2007 to November 2015, where Mattias focused on medical liaison roles in neuroscience and diabetes, engaging in thought leader management and advisory board activities. Mattias earned a Master of Science in Pharmacy from Uppsala University between 2002 and 2007.